- Home
- LIXT vs NIVF Comparison
LIXT vs NIVF Comparison
Compare LIXT & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- NIVF
- Stock Information
- Founded
- LIXT 2005
- NIVF 2011
- Country
- LIXT United States
- NIVF Thailand
- Employees
- LIXT N/A
- NIVF N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- NIVF
- Sector
- LIXT Health Care
- NIVF
- Exchange
- LIXT Nasdaq
- NIVF NYSE
- Market Cap
- LIXT 2.2M
- NIVF 2.1M
- IPO Year
- LIXT N/A
- NIVF N/A
- Fundamental
- Price
- LIXT $4.00
- NIVF $0.62
- Analyst Decision
- LIXT
- NIVF
- Analyst Count
- LIXT 0
- NIVF 0
- Target Price
- LIXT N/A
- NIVF N/A
- AVG Volume (30 Days)
- LIXT 6.2M
- NIVF 3.8M
- Earning Date
- LIXT 08-07-2025
- NIVF 01-01-0001
- Dividend Yield
- LIXT N/A
- NIVF N/A
- EPS Growth
- LIXT N/A
- NIVF N/A
- EPS
- LIXT N/A
- NIVF N/A
- Revenue
- LIXT N/A
- NIVF $5,433,375.00
- Revenue This Year
- LIXT N/A
- NIVF N/A
- Revenue Next Year
- LIXT N/A
- NIVF N/A
- P/E Ratio
- LIXT N/A
- NIVF N/A
- Revenue Growth
- LIXT N/A
- NIVF 5.79
- 52 Week Low
- LIXT $0.64
- NIVF $0.61
- 52 Week High
- LIXT $4.45
- NIVF $656.00
- Technical
- Relative Strength Index (RSI)
- LIXT 80.89
- NIVF 27.45
- Support Level
- LIXT $2.02
- NIVF $0.61
- Resistance Level
- LIXT $4.25
- NIVF $1.24
- Average True Range (ATR)
- LIXT 0.54
- NIVF 0.12
- MACD
- LIXT 0.30
- NIVF 0.03
- Stochastic Oscillator
- LIXT 96.99
- NIVF 2.36
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.